A Phase II Trial of Teclistamab in Participants With Previously Treated Immunoglobulin Light-chain (AL) Amyloidosis

NCT06649695 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

30

Enrollment

NETWORK

Sponsor class

Conditions

AL Amyloidosis

Interventions

DRUG: Teclistamab

Sponsor

European Myeloma Network B.V.

Collaborators

[object Object]